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Abstract
Background: Breast cancer represented 35.1 % of total female cancer cases in Egypt. Seroma is one of the most
serious and common complications of mastectomy and axillary dissection with incidence between 15 and 81 %.
Seroma formation delays wound healing and increases susceptibility to infection, skin flap necrosis, and persistent
pain as well as prolonging convalescence. Therefore, several techniques have been investigated to minimize
seroma formation with no consistent success. Axillary exclusion is a technique aimed to obliterate dead space after
axillary clearance and minimize collection.
Methods: Sixty-four patients were prepared for modified radical mastectomy. Of those, the study group contains
32 patients and the control group contains 32 patients. Study group had axillary exclusion while the other had the
conventional procedure; total drain outputs were recorded daily for all patients prior to drain removal. The drains
were removed when the daily drainage was less than 30 ml.
Results: This study contains 64 patients, the study group contains 32 patients, and the control group contains 32
patients. Age, BMI (mean control = 31.7 and study = 30.2), and tumor size were of no significant differences to be
more concise on the effect of axillary exclusion. The mean of day of drain removal in the control group was
17.8 day (15–19) with a mean of total drain output of 4525.6 ml (4430–3660 ml) while the mean in the study group
of day of drain removal was 11.3 (10–13) with a mean of total drain output of 1476.2 ml (620–2200 ml), p < 0.00.
Conclusions: Axillary exclusion technique is a valuable procedure that significantly decreases seroma
postmastectomy and axillary dissection.
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Background
Breast cancer is the most common malignancy among
women in most developed and developing regions of the
world with nearly a million new cases each year [1]. In a
recent epidemiological study in the Egyptian cancer in-
stitute, breast cancer represented 35.1 % of the total fe-
male cancer cases in Egypt [2]. Modified radical
mastectomy is the most common form of breast cancer
treatment [3]. Patients at a higher risk for postoperative
complications are patients with diabetes, smokers, pa-
tients with a history of prior chest wall radiation, and
other patients with diffuse small vessel disease. After an
axillary dissection, along with the normal local healing
issues, the alteration of the regional lymphatic system
puts patients at an increased risk of complications [4].
The incidence of seroma is correlated with certain fac-
tors. Obesity, patient’s age, hypertension, breast volume,
presence of malignant nodes in the axillary region, num-
ber of metastatic nodes, number of dissected nodes,
early shoulder exercise, and the use of some drugs, i.e.,
tamoxifen and heparin, affect the pathophysiology.
While the use of electrocautery decreases bleeding, it in-
creases total drain output, causing a higher rate of ser-
oma formation [5, 6]. Theories of etiology are important
in determining the most likely surgical technique for
prevention. Various techniques have been studied in an* Correspondence: m.faisal@med.suez.edu.eg
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attempt to minimize postmastectomy drainage volumes
and the incidence of seroma. None however have been
found to be consistently successful, and consequently,
none are used in the common practice. If it is believed
that the lymphatics disruption in the axillary fossa are
main aetiology, it follows that obliterating this space will
minimize fluid collection [7, 8].
Methods
This study is a randomized controlled trial that took
place in Surgery Department, Suez Canal University
Hospital, from November 2013 to August 2014. This
research has been reviewed by our research ethics
committee in the Faculty of Medicine-Suez Canal
University at its meeting on 23/4/2014 with reference
number (#2115).
Target population was 64 patients among those who
referred to outpatient clinics. The sample size was
calculated as 32 patients for each group, using Med-
Clac Version 11.4 software. This number of patients
was large enough to detect a difference in the mean
“number of days before drain removal” of 20 days
(±23.5 days pooled standard deviation), at 5 % alpha
error, 10 % beta error, and 10 % dropout rate.
Those 64 patients were recruited to our study accord-
ing to the inclusion and exclusion criteria. Inclusion cri-
teria were any patients presented to the surgery
outpatient clinic with breast cancer and planned for
modified radical mastectomy, and exclusion criteria were
(1) patients arranged for conservative breast surgery and
sentinel lymph node, (2) patients with advanced breast
cancer and arranged for palliative mastectomy, and (3)
patients arranged for breast reconstruction at the same
session. Then, they were randomly allocated to either
the control or study groups. Random sequence was gen-
erated by Microsoft Excel program using random func-
tions. The surgeon was given randomly generated
treatment allocations within sealed opaque envelopes.
Once a patient has consented to enter the trial, this en-
velope was opened and the patient then underwent the
allocated surgery Thirty-two patients were equally and
randomly assigned as the study group, and the control
group contains thirty-two patients. The technique was
performed by a single surgeon and involved skin flap
dissection and excision of the breast with pectoral fascia,
and the dissection of axillary lymph nodes were per-
formed with a diathermy (Fig. 1a). Control of the small
bleeding vessels was sustained with coagulate mood of
diathermy. Suturing the superior mastectomy skin flap
down to the free edge of pectoralis major and the lateral
chest wall was done using a continuous 2/0 vicryl stitch;
then, four to six interrupted sutures were placed be-
tween pectoralis major and minor to reliably exclude the
axillary fossa from the remainder of the mastectomy
cavity (Fig. 1b). 14F suction drains were placed at sur-
gery in all patients with the tip placed within the mast-
ectomy cavity outside the obliterated axilla; then,
pressure dressing was applied. Total drain outputs were
recorded daily for all patients prior to drain removal.
The drains were removed when the daily drainage was
less than 30 ml.
Results
Both study groups contains and control group com-
prised 32 patients. The mean age in the study group
was 48.9 ± 4.1 years versus 47.5 ± 2.3 years in the con-
trol group with no significant difference. The mean
BMI of the study group, 30.2 ± 2 %, did not show any
significant statistical difference from the control group,
31.7 ± 1 %. Similarly, the mean tumor size in the study
Fig. 1 Study intra operative images show (a) axillary fossa after
mastectomy and axillary clearance and (b) axillary exclusion: the
technique was performed by a single surgeon and involved skin flap
dissection and the excision of the breast with pectoral fascia, and
the dissection of axillary lymph nodes were performed with a
diathermy (a). Control of the small bleeding vessels was sustained
with coagulate mood of diathermy. Suturing the superior
mastectomy skin flap down to the free edge of pectoralis major and
the lateral chest wall was done using a continuous 2/0 vicryl stitch,
and then, four to six interrupted sutures were placed between
pectoralis major and minor to reliably exclude the axillary fossa from
the remainder of the mastectomy cavity (b)
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group, 3 × 2.2 cm, did not differ significantly than the con-
trol group 2.9 × 2.8 cm. The total amount of the drain out-
put was compared in both groups. The mean total
amount in the study group was 1476.2 ± 518 ml while
the mean in the control group was 4525.6 ± 97.6 ml.
The results show a significant reduction in the total
amount of the drain output p < 0.001 (Table 1). There
was a significant reduction in the daily amount of the
seroma in the study group who underwent axillary
exclusion p < 0.05 (Fig. 2). There was a significant dif-
ference in the results between the study and the con-
trol group regarding the day of the drain removal as
the mean of the days before drain removal in study
group was 11.3 ± 1.3 day while in the control group
was 17.8 ± 1 day p < 0.001 (Table 2). For the distribu-
tion of the participants according to the list of
postoperative complications in both groups, in the
study group, there was 91.2 % of patients with no
postoperative complications, 5.9 % developed wound
infection, 2.9 % developed ischemic flaps, and there
was no one developed reaccumulation or wound de-
hiscence while the control group showed 73.8 % of
patients with no postoperative complications, 11.7 %
developed infection, 8.8 % developed ischemic flaps,
2.9 % reaccumulation, and 2.9 % developed wound
dehiscence (Fig. 3).
Discussion
Axillary dissection remains an integral part of breast
cancer treatment for prognostic and curative purposes
[9]. It is possible to avoid axillary dissection in selected
patients (T1N0) using the sentinel lymph node tech-
nique. However, in the majority of cases, axillary lymph-
nectomy is not avoidable and still has complications, in
particular seroma formation (15–81 %), which can delay
the patient’s discharge, healing, and supplementary
radiotherapy and chemotherapy treatments [10, 11].
Various studies have attempted to reduce seroma forma-
tion in order to improve outcome and reduce morbidity.
Techniques that have been advocated over the years
include shoulder immobilization, prolonged suction
drainage perioperative tranexamic acid, choice of surgi-
cal instrument, and obliteration of dead space [12]. Elec-
trocautery has been described as possibly increasing the
frequency of seroma. Contrary to the popular belief, a
study has shown that the length of time drains that are
left in place does not affect seroma rate. Few results
have shown consistent benefit time of initiation of arm
movement has also been studied on the basis that chest
wall motion and shoulder use create shearing forces that
delay flap adherence and that postoperative arm use acts
as a pump forcing lymph into the empty axillary fossa
[13]. However, studies have shown no significant
Table 1 Distribution of patients according to total drain output
Study groups p value
Control (n = 32) Axillary exclusion (n = 32)
Mean ±SD Range Mean ±SD Range
Total drain output (ml) 4525.6 97.6 4430–3660 1476.2 518 620–2200 <0.001*
*Statistically significant at p < 0.05




































Fig. 2 Distribution of patients according to daily drain output (ml). Significant reduction of the daily amount of the seroma in the study group
who underwent axillary exclusion, p < 0.05
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difference when delaying rehabilitation, and in fact, the
consequences of shoulder stiffness can be far greater
than that of simple seroma [14, 15]. We believe that
postoperative fluid collections following mastectomy and
axillary clearance arise from disrupted axillary lym-
phatics to a greater extent than serous fluid formation
from mastectomy flaps. We have shown that reliably ex-
cluding the axillary fossa from the remainder of the
mastectomy wound can considerably reduce postopera-
tive drainage volume in this small group of patients.
More importantly, this technique significantly reduces
clinically apparent seromas after drain removal, thereby
reducing the consequences of patient anxiety, discom-
fort, and added morbidity [16]. Previous studies of
seroma formation after breast surgery have often been
small in scale and poor in quality, and none have
clearly demonstrated a difference in overall patient-
rated quality of life or cost-effectiveness as a result of
mechanical closure of the dead space (Classe JM et al.
2006). However, the findings suggest that routine use of a
pressure garment or compression dressing is not
warranted. In contrast, closure of the dead space by flap
fixation with sutures will reduce seroma formation and
the number of aspirations, thus simplifying postoperative
management and facilitating early discharge. This tech-
nique may preclude the use of drains in breast surgery, es-
pecially in BCS [17].
Yiping Gong, MB, [18], studied 200 breast cancer
patients randomly divided into 2 groups: group 1 was
operated by using ligation all of the tissue connecting
axillary vein bundles to the specimen, suturing the an-
terior edge of the latissimus dorsi to the chest wall, and
fix the skin flap to the underlying muscle by subcutane-
ous sutures while group 2 was operated on using the
conventional technique. The drainage volume, in the ini-
tial 3 days, for patients in group 1 was significantly less
than that for patients in group 2 (P < 0.01). The duration
of drainage in group 1 was shorter than that in group 2
(P < 0.01). The incidence of seroma formation in the
study group (2 %) was significantly less than that in
group 2 (14 %) (P < 0.01).
Conclusions
Axillary exclusion is a simple technique that reduces sig-
nificantly the total amount of seroma formation postop-
eratively, the psychological burden of long time drain,
postoperative visits for drain follow-up, and complica-
tions related to seroma accumulation after breast cancer
surgery. However, we recommend that this technique
should be tried on a much wider scale to prove its valid-
ity in decreasing the incidence of seroma formation and
its subsequent complications, so that it can be intro-
duced as a step in the mastectomy operations.
Table 2 Distribution of patients according to day of drain removal
Study groups p value
Control (n = 32) Axillary exclusion (n = 32)
Mean ±SD Range Mean ±SD Range
Days before drain removal 17.8 1.0 15–19 11.3 1.3 10–13 <0.001*
*Statistically significant at p < 0.05
Fig. 3 Distribution of patients according to postoperative complications. For the distribution of the participants according to the list of
postoperative complications in both groups, in the study group, there was 91.2 % of patients with no postoperative complications, 5.9 %
developed wound infection, 2.9 % developed ischemic flaps, and there was no one developed reaccumulation or wound dehiscence while the
control group showed 73.8 % of patients with no postoperative complications, 11.7 % developed infection, 8.8 % developed ischemic flaps, 2.9 %
reaccumulation, and 2.9 % developed wound dehiscence
Faisal et al. World Journal of Surgical Oncology  (2016) 14:39 Page 4 of 5
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MF carried out the surgical procedures, conceived of the study, participated
in the study design and the sequence alignment, and drafted the manuscript
and critical revision. ATA participated in study design and surgical procedures
and helped to draft the manuscript and critical revision. WMG participated in
acquisition of date and sequence alignment and performed the statistical
analysis. OA participated in study design, coordination, and critical revision.
All authors read and approved the final manuscript.
Acknowledgements
Special thanks, admiration, and respect to all our department members for
their kind help, guidance, and valuable support.
Received: 28 October 2015 Accepted: 17 February 2016
References
1. Ozdoğan M, Yılmaz KB, Ozaslan C, Gurer A, Gulbahar O, Ersoy E. Scalpel versus
electrocautery dissections: the effect on wound complications and pro-
inflammatory cytokine levels in wound fluid. Turk J Med Sci. 2008;38:111–6.
2. Hokkam E, Farrag S, El Kammash S. Tetracycline sclerotherapy in treating
postmastectomy seroma: a simple solution for a frequently occurring
problem. Egyptian J Surgery. 2009;28:99–104.
3. Hashemi E, Kaviani A, Najafi M, Ebrahimi M, Hooshmand H, Montazeri A. Seroma
formation after surgery for breast cancer. World J Surg Oncol. 2004;2:44.
4. Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, et al.
Evidence-based risk factors for seroma formation in breast surgery. Clin
Oncol. 2006;36(4):197–206.
5. Badwe RA. Influence of surgical technique on axillary seroma formation:
a randomized study. ANZ J Surg. 2007;77:385–9.
6. Coveney EC, O’Dwyer PJ, Geraghty JG, O’Higgins NJ. Effect of closing dead
space on seroma formation after mastectomy—a prospective randomized
clinical trial. Eur J Surg Oncol. 1998;19:143–6.
7. Chand N, Anna M, Aertssen G, Royle GT. Axillary exclusion a successful
technique for reducing seroma formation after mastectomy and axillary
dissection. Advances Breast Cancer Ress. 2012;2:1–6.
8. Gonzalez EA, Saltzstein EC, Riedner CS, Nelson BK. Seroma formation
following breast cancer surgery. Breast J. 2003;9:385–8.
9. Throckmorton AD, Askgard Giesmann J, Hoskin TL, Bjarnason H, Donohue
JH, Boughey JC, et al. Sclerotherapy for the treatment of post mastectomy
seroma. Am J Surg. 2008;196(4):541–4.
10. Van Heurn LW, Brink PR. Prospective randomized trial of high versus low
vacuum drainage after axillary lymphadenectomy. Br J Surg. 1995;82:931–2.
11. Unalp HR, Onal MA. Analysis of risk factors affecting the development of
seromas following breast cancer surgeries: seromas following breast cancer
surgeries. Breast J. 2007;13:588–92.
12. Pogson CJ, Adwani A, Ebbs SR. Seroma following breast cancer surgery.
Eur J Surg Oncol. 2003;29:711–7.
13. Purkayastha J, Hazarika S, Deo SV, Kar M, Shukla NK. Post-mastectomy chylous
fistula: anatomical and clinical implications. Clin Anat. 2004;17:413–5.
14. Lindsey WH, Masterson TM, Spotnitz WD, Wilhelm MC, Morgan RF.
Seroma prevention using fibrin glue in a rat mastectomy model. Arch Surg.
1990;125(3):305–7.
15. Moore MM, Nguyen DH, Spotnitz WD. Fibrin sealant reduces serous
drainage and allows for earlier drain removal after axillary dissection:
a randamiosed prospective trial. Am Surg. 1997;63(1):97–103.
16. Rice DC, Morris SM, Sarr MG, Farnell MB, Van Heeden JA, Grant CS, et al.
Intra operative topical tetracycline sclerotherapy following mastectomy:
a prospective randomized trial. J Surg Oncol. 2000;73(4):224–7.
17. Classe JM, Berchery D, Campion L et al. Randomized clinical trial comparing
axillary padding with closed suction drainage for the axillary wound after
lymphadenectomy for breast cancer. Br J Surg. 2006;93:820–4.
18. Yiping Gong MB, Juan Xu MB, et al. prevention of seroma formation after
mastectomy and axillary dissection by lymph vessel ligation and dead
space closure: a randomized trial. J AM Surg, 2010;200(3):352–6
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Faisal et al. World Journal of Surgical Oncology  (2016) 14:39 Page 5 of 5
